- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made).
64. For Schedule 9 substitute the following Schedule—
Regulation 47(1)
1. The modifications of the 2012 Regulations mentioned in regulation 47 are as follows.
2. In regulation 2 (medicinal products)—
(a)at the beginning of paragraph (1) insert “Subject to paragraph (3),”; and
(b)after paragraph (2) insert the following paragraph—
“(3) “Medicinal product” includes any investigational medicinal product.”.
2. In regulation 8(1) (interpretation)—
(a)the definition “assemble” is substituted by the definition of that expression in regulation 2(1) of these Regulations; and
(b)there is inserted in the appropriate position in alphabetical order a definition “container” in the same terms as the definition of that expression in regulation 2(1) of these Regulations; and
(c)the definition “qualified person” is substituted by the definition of that expression in regulation 2(1) of these Regulations.
3. In regulation 322(1) (validity of decisions and proceedings) omit “or” and insert a comma before “8 (Article 126a authorisations)”, and after those words insert “or the Clinical Trials Regulations”.
4. In regulation 325(1) (rights of entry) insert after sub-paragraph (b) the following sub-paragraph—
“(ba)in order to verify any statement contained in an application or request for an authorisation under the Clinical Trials Regulations;”.
5.—(1) Regulation 327 (powers of inspection, sampling and seizure) is amended as follows.
(2) In paragraph (1)—
(a)after sub-paragraph (b) omit “; or”;
(b)after sub-paragraph (c) insert “; or” and the following sub-paragraph—
“(d)in order to verify any statement contained in an application or request for an authorisation under the Clinical Trials Regulations.”.
(3) After paragraph (2)(g) insert the following sub-paragraph—
“(h)information and documents relating to clinical trials”.
(4) In paragraph (3)—
(a)omit “or” following sub-paragraph (a); and
(b)following paragraph (b) insert “; or” and the following sub-paragraph—
“(c)a medicinal product used, or intended to be used, in a clinical trial”.
(5) In paragraph (4)—
(a)after “require” insert “— (a)”; and
(b)after “control” insert “; or” and the following sub-paragraph—
“(b)a person associated with a clinical trial to produce information or documents relating to the clinical trial which are in the person’s possession or under the person’s control”.
(6) In paragraph (5)(a) for “(2)(f) or (g)” substitute “(2)(f), (g) or (h)”.
(7) After paragraph (9) insert the following paragraph—
“(10) In this regulation, “a person associated with a clinical trial means any of the following—
(a)the sponsor of a clinical trial (within the meaning of regulation 3 of the Clinical Trials Regulations);
(b)any person who, under arrangements made with the sponsor of a clinical trial, carries out functions of the sponsor of the trial;
(c)in investigator for a clinical trial (within the meaning of regulation 2(1) of the Clinical Trials Regulations);
(d)any person, other than an investigator, who conducts a clinical trial;
(e)any person occupying premises at which a clinical trial is being conducted; or
(f)any person who, in the course of employment with a person listed in any of sub-paragraphs (a) to (e), undertakes activities in connection with a clinical trial.”.
(8) In regulation 335(6) (contravention due to fault of another person) omit “and” after sub-paragraph (e) and after sub-paragraph (f) insert “; and” and the following sub-paragraph—
“(g)any obligation or prohibition under the Clinical Trials Regulations”.
(9) In regulation 336(3) (warranty as defence) omit “and” after sub-paragraph (c) and after sub-paragraph (d) insert “; and” and the following sub-paragraph—
“(e)regulation 46 of the Clinical Trials Regulations (labelling)”.”
The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
The Whole Instrument you have selected contains over 200 provisions and might take some time to download.
Would you like to continue?
The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
The Whole Instrument without Schedules you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
The Schedules you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Impact Assessments generally accompany all UK Government interventions of a regulatory nature that affect the private sector, civil society organisations and public services. They apply regardless of whether the regulation originates from a domestic or international source and can accompany primary (Acts etc) and secondary legislation (SIs). An Impact Assessment allows those with an interest in the policy area to understand:
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: